Purchase Order 36C24726P0296
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2.27 million firm fixed-price purchase order by the Department of Veterans Affairs through Veterans Integrated Service Network 20 for the lease and purchase of a molecular diagnostic testing system along with instrument-specific assays. The contract, awarded on August 1, 2022, with an ultimate completion date of July 31, 2027, carries no set-aside designation and represents part of the VA's broader reliance on Cepheid as a...
- Cepheid has been awarded a firm fixed-price delivery order valued at $40,704.72 by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, with an ultimate completion date of May 31, 2025, is for molecular diagnostic solutions to be delivered and performed in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of advanced diagnostic systems and testing solutions to the...
- Cepheid has been awarded a $29,750 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VA - VHA VISN 20) to deliver GENEXPERT IV-4 SITE SYSTEM, XPRESS GXIV-4-CLIA diagnostic equipment and services. The firm fixed price contract runs from September 7, 2023 through October 7, 2023 and will be performed in Sunnyvale, California by Cepheid as the prime contractor. The GENEXPERT IV-4 SITE SYSTEM, XPRESS GXIV-4-CLIA will provide...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a purchase order valued at $673,895.56 by Veterans Integrated Service Network 8 (VISN 8) for microbiology cost-per-test services. The contract, awarded on October 1, 2025, will be performed in Sunnyvale and extends through September 30, 2026. This firm fixed-price purchase order contains no set-aside designation and represents a continuation of Cepheid's established role as a primary supplier of molecular diagnostic testing...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order by the Department of Veterans Affairs (Veterans Integrated Service Network 21) on October 1, 2024, for GeneXpert test kits valued at $505,664.35. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, will be performed in San Francisco, California. No set-aside designation was used for this procurement. This award represents a...
- The Department of Veterans Affairs' Veterans Integrated Service Network 10 awarded a $79,343.96 firm fixed-price purchase order to Cepheid Inc. for GeneXpert diagnostic supplies effective January 1, 2026 with completion by March 31, 2026. Cepheid, a molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for detecting infectious diseases and other medical conditions. This purchase order represents a routine procurement...
- Cepheid, a leading molecular diagnostic manufacturer based in Sunnyvale, California, has been awarded a delivery order valued at $168,765 by the Department of Veterans Affairs' Veterans Integrated Service Network 19 for the purchase of Cepheid GeneXpert analyzers. The award, issued on September 19, 2025, with an ultimate completion date of September 20, 2026, carries a firm fixed-price structure with no set-aside designation. The equipment will be delivered to the VA facility in Tulsa, Oklahoma....
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a Blanket Purchase Agreement (BPA) call valued at $1.87M by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19), with an award date of October 1, 2024, and ultimate completion by September 30, 2025. This firm fixed-price procurement, which utilized no set-aside designation, is issued under the General Services Administration's Multiple Award Schedule (MAS) contracting vehicle. Cepheid will...
- Cepheid Inc., a leading manufacturer of molecular diagnostic systems based in Sunnyvale, California, was awarded a delivery order valued at $970,216.62 on October 1, 2025, for Cepheid Molecular Diagnostic Testing System reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6). This firm fixed-price delivery order, which extends through March 31, 2026, carries no set-aside designation and will be performed in Sunnyvale, California. The award funds the supply of molecular...
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $179.7K firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 7 (VISN 7) on January 29, 2026, for a GeneXpert IV-4 Site System, with performance to be completed by April 27, 2026. The award carries no set-aside designation, reflecting Cepheid's established competitive position as a primary federal supplier of molecular diagnostic systems and reagents. This purchase order represents a discrete equipment acquisition supporting VISN 7's clinical laboratory operations across its network of medical centers. This award aligns with Cepheid's broader role as a core diagnostic solutions provider to the VA system. The company currently holds two significant Indefinite Delivery Contracts with the VA—a $6.7M single-award IDC with VISN 17 extending through December 2029 and a substantially larger $32.8M single-award IDC with VISN 6 extending through September 2030—that establish ongoing procurement frameworks for GeneXpert diagnostic systems, molecular testing reagents, assays, and associated maintenance services across the VA healthcare network. Cepheid's federal portfolio additionally encompasses contracts with the Indian Health Service, Defense Health Agency, Defense Logistics Agency, and U.S. Coast Guard for comparable diagnostic capabilities, positioning the company as a dominant supplier of rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other clinical conditions throughout the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $179.7k | 1/28/26 |